Primary myelofibrosis: own experience and news from diagnostic and treatment
The newest advances in primary myelofibrosis (PMF) pathogenesis study, diagnostic and treatment approaches are presented in this article. The JAK-STAT signal pathway activation now recognized as main pathogenesis mechanism of PMF, it caused by JAK2, CALR, MPL genes mutations. Authors demonstrate the...
Saved in:
| Main Authors: | K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2015-06-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/142 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
All we know about polycythemia vera: literature review and own experience
by: K. M. Abdulkadyrov, et al.
Published: (2015-10-01) -
Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis
by: M. S. Fominykh, et al.
Published: (2016-08-01) -
Case report: Successful use of ruxolitinib to treat interstitial pneumonia as an unusual primary presentation in primary myelofibrosis—two birds with one stone
by: Pingping Xiao, et al.
Published: (2024-11-01) -
Current Genetic Models for Prediction of Primary Myelofibrosis
by: LB Polushkina, et al.
Published: (2019-09-01) -
THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA
by: A. A. Zhernyakova, et al.
Published: (2017-06-01)